PRAXIS PRECISION MEDICINES, INC. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
PRAXIS PRECISION MEDICINES, INC. (PRAX) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $0 as of 2025-12-31, per its 10-K filed 2026-02-19.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-02-19
- 2025-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $0.00.
- 2024-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $62.00K.
- 2023-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $232.00K.
- 2022-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $497.00K.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-19 |
| 2024-12-31 | $62.00K 10-K · filed 2025-02-28 |
| 2023-12-31 | $232.00K 10-K · filed 2024-03-05 |
| 2022-12-31 | $497.00K 10-K · filed 2023-02-07 |
| 2021-12-31 | $846.00K 10-K · filed 2022-02-28 |
| 2021-09-30 | $942.00K 10-Q · filed 2021-11-03 |
| 2021-06-30 | $1.03M 10-Q · filed 2021-08-16 |
| 2020-12-31 | $28.00K 10-K · filed 2021-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |